Skip to content

Effect of esketamine on Propofol ED50 in intravenous anesthesia for painless abortion

Effect of esketamine on Propofol ED50 in intravenous anesthesia for painless abortion

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300068857
Enrollment
Unknown
Registered
2023-03-01
Start date
2023-02-27
Completion date
Unknown
Last updated
2023-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anesthetic drugs are used in painless abortion

Interventions

E1 group:Propofol + Esketamine 0.1mg/kg
E2 group:Propofol + Esketamine 0.15mg/kg

Sponsors

The First Affiliated Hospital of Anhui Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Patients undergoing elective painless abortion, ASAI-II grade 2. Age 18-45 3. BMI 18.5-24 kg/m2 4. No obvious cardiopulmonary disease 5. Normal communication 6. Volunteers and sign informed consent

Exclusion criteria

Exclusion criteria: (1) Severe respiratory and circulatory diseases, such as severe coronary atherosclerosis Sclerosis, heart failure, myocardial infarction, respiratory failure and other underlying diseases (2) neurological diseases: such as severe cerebral hemorrhage or sequelae of cerebral infarction, hemiplegia, aphasia (3) mental illness: such as schizophrenia, depression and so on (4) Long-term drug abuse: including chemotherapy drugs, analgesics, etc (5) Complicated with obvious abnormal liver and kidney function (6) Patients with possible difficult airway, high intracranial pressure and high intraocular pressure (7) Patients allergic to anesthetic drugs such as propofol and esketamine (8) History of vaginal delivery

Design outcomes

Primary

MeasureTime frame
Propofol ED50;Incidence of respiratory depression;

Secondary

MeasureTime frame
Blood pressure, heart rate, pulse oxygen saturation;The propofol injection hurts;Propofol initial dose maintenance time;BPS-NI score;Recovery time;Total amount of propofol;Retention time of PACU;Adverse reaction;VAS score;

Countries

China

Contacts

Public ContactXuesheng Liu

The First Affiliated Hospital of Anhui Medical University

liuxuesheng@ahmu.edu.cn+86 186 5519 3385

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026